期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

肝脏脂肪变性对慢性乙型肝炎影响的研究进展 被引量：1

Influence of hepatic steatosis on chronic hepatitis B
下载PDF
导出
摘要 近年来,随着体质量超标和/或肥胖发病率的增高,非酒精性脂肪性肝病(nonalcoholicfatty liver disease,NAFLD)的发病率呈上升趋势.慢性乙型肝炎(chronic hepatitis B,CHB)病毒感染是另一种常见的慢性肝病.事实上,NAFLD合并CHB在临床上非常常见.在本文中,我们概述了NAFLD和CHB的关系,NAFLD对CHB的影响,以及代谢综合征在肝纤维化、肝硬化以及肝细胞癌的发展过程中所发挥的作用.此外,本文还将讨论关于CHB易于合并发生NAFLD原因的最新进展.同时探讨NAFLD对CHB治疗的不利影响.NAFLD合并CHB患者肝功能异常原因的诊断和治疗对临床医生来说是一个难点.并且,NAFLD合并CHB时肝脏承受双重打击,进行适当的治疗和管理显得尤为重要. Worldwide, nonalcoholic fatty liver disease（NAFLD） has a high prevalence with the rising rates of overweight and/or obesity. Chronic hepatitis B（CHB） virus infection is another common cause of infectious liver diseases. In practice, the overlap between NAFLD and CHB is rather common. In this review, we summarize the relationship between NAFLD and CHB, the influence of NAFLD on CHB, and the role of the metabolic syndrome in the development of hepatic fibrosis, cirrhosis and hepatocellular carcinoma. Recent advances in understanding the reason CHB is prone to overlap NAFLD will be discussed. The adverse effects caused by NAFLD on the treatment and progression of CHB will be also elucidated. NAFLD overlapping CHB often raises a great challenge to the clinicians, in terms of diagnosis or treatment. Therefore, appropriate management of this complex situation is needed.
作者 金丽鑫 洪美珠
机构地区 厦门大学附属中山医院消化内科 厦门大学附属中山医院中医科
出处 《世界华人消化杂志》 CAS 2016年第9期1366-1371,共6页 World Chinese Journal of Digestology
关键词 肝脏脂肪变性 慢性乙型肝炎 代谢综合征 双重打击 Hepatic steatosis Chronic hepatitis B Metabolic syndrome Double damage
分类号 R512.62 [医药卫生—内科学]
  • 相关文献

参考文献50

  • 1Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HL, Chen CJ, Chen DS, Chen HL, Chen PJ, Chien RN, Dokmeci AK, Gane E, Hou JL, Jafri W, Jia J, Kim JH, Lai CL, Lee HC, Lira SG, Liu CJ, Locarnini S, A1 Mahtab M, Mohamed R, Omata M, Park J, Piratvisuth T, Sharma BC, Sollano J, Wang FS, Wei L, Yuen MF, Zheng SS, Kao JH. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int 2016; 10:1-98 [PMID: 26563120 DOI: 10.1007/ s12072-015-9675-4].
  • 2Pais R, Rusu E, Zilisteanu D, Circiumaru A, Micu L, Voiculescu M, Poynard T, Ratziu V. Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease. Eur J Intern Med 2015; 26:30-36 [PMID: 25553983 DOI: 10.1016/j.ejim.2014.12.001].
  • 3Younossi ZM, Stepanova M, Afendy M, Fang Y, Younossi Y, Mir H, Srishord M. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 2011; 9: 524-530. el; quiz e60 [PMID: 21440669 DOI: 10.1016/ j.cgh.2011.03.020].
  • 4Farrell GC, Wong VW, Chitturi S. NAFLD in Asia-as common and important as in the West. Nat Rev Gastroenterol Hepatol 2013; 10:307-318 [PMID: 23458891 DOI: 10.1038/nrgastro.2013.34].
  • 5Fan JG, Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol 2009; 50:204-210 [PMID: 19014878 DOI: 10.1016/ j.jhep.2008.10.010].
  • 6Li Y, Xu C, Yu C, Xu L, Miao M. Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study. J Hepatol 2009; 50:1029-1034 [PMID: 19299029 DOI: 10.1016/j.jhep.2008.11.021].
  • 7Lee M, Kowdley KV. Alcohol's effect on other chronic liver diseases. Clin Liver Dis 2012; 16:827-837 [PMID: 23101984 DOI: 10.1016/ j.cld.2012.08.010].
  • 8Park SH, Jeon WK, Kim SH, Kim HJ, Park DI, Cho YK, Sung IK, Sotm CI, Keum DK, Kim BI. Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol 2006; 21:138-143 [PMID: 16706825 DOh 10.1111/j.1440-1746.2005.04086.x].
  • 9Chen CH, Huang MH, Yang JC, Nien CK, Yang CC, Yeh YH, Yueh SK. Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan. J Gastroenterol Hepatol 2007; 22:1482-1489 [PMID: 17716352 DOI: 10.1111/j.1440-1746.2006.04615.x].
  • 10Tsai CH, Li TC, Lin CC. Metabolic syndrome as a risk factor for nonalcoholic fatty liver disease. South Med J 2008; 101:900-905 [PMID: 18708987 DOI: 10.1097/SMJ.0b013e31817e8af9].

二级参考文献15

  • 1Taylor BC, Yuan JM, Shamliyan TA, et al. Clinical outcomes in adults with chronic hepatitis B in association with patient and viral characteristics: A systematic review of evidence. Hepatology, 2009, 49(5 Suppl): S85-95.
  • 2Cheung O, Sanyal AJ. Hepatitis C infection and nonalcoholic fatty liver disease. Clin Liver Dis, 2008, 12: 573-585.
  • 3Fan JG, Chitturi S. Hepatitis B and fatty liver: causal or coincidental? J Gastroenterol Hepatol, 2008, 23: 679-681.
  • 4Cross TJ, Quaglia A, Hughes S, et al. The impact of hepatic steato- sis on the natural history of chronic hepatitis C infection. J Viral Hepat, 2009, 16: 492-499.
  • 5Fan JG, Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol, 2009, 50: 204-210.
  • 6Shi JP, Fan JG, Wu R, et al. Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection. J Gastroenterol Hepatol, 2008, 23: 1419-1425.
  • 7Petta S, Camma C, Di Marco V, et al. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection. Am J Gastroenterol, 2008, 103: 1136-1144.
  • 8Tsochatzis E, Papatheodoridis GV, Hadziyannis E, et al. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity. Scand J Gastroenterol, 2008, 43:1128-1136.
  • 9Jonsson JR, Barrie HD, O'Rourke P, et al. Obesity and steatosis influence serum and hepatic inflammatory markers in chronic hepatitis C. Hepatology, 2008, 48: 80-87.
  • 10Machado MV, Cortez-Pinto H. Insulin resistance and steatosis in chronic hepatitis C. Ann Hepatol, 2009, 8(Suppl 1): S67-75.

共引文献41

同被引文献6

二级引证文献2

世界华人消化杂志
2016年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部